Novartis Gets Another Summary Judgment and Daubert Win Shortly Before Trial
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- July 2, 2014
Garrison v. Novartis Pharm. Corp., 2:11-cv-00589 (M.D. Ala. July 2, 2014)
Florida Court Dismisses Punitive Damages Claims in Aredia/Zometa Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 16, 2014
Novartis Pharmaceuticals secured dismissal of punitive damages demands in the Middle District of Florida, joining the vast majority of other courts in the Aredia/Zometa litigation in holding that New Jersey law governs the question of punitive…
New Jersey Court Grants Novartis Summary Judgment in Bellwether Trial Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 6, 2014
Novartis Pharmaceuticals Corporation achieved a victory when Judge Jessica Mayer granted Novartis’s motions to exclude a plaintiff’s case-specific expert and for summary judgment in one of four cases selected for potential bellwether trial this Fall. Though…
In its opinion, the U.S. Court of Appeals for the District of Columbia affirmed a series of district court rulings dismissing the large majority of claims brought by three Ecuadorian provinces and over 2,000 individual Ecuadorian…
5th Circuit Finds for Novartis, Affirming Dismissal of Aredia/Zometa Suit
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- May 27, 2014
The U.S. Court of Appeals for the Fifth Circuit affirmed a summary judgment ruling in favor of Novartis Pharmaceuticals Corporation dismissing all of the plaintiff’s claims in a pharmaceutical products liability action arising out of the…
North Carolina Federal Jury Returns Defense Verdict in Favor of Novartis
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- May 14, 2014
Following a full day’s deliberations, a federal jury in Raleigh, North Carolina, returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation after a seven-day trial involving Aredia and Zometa, medicines used to prevent the devastating…
Novartis Prevails on Summary Judgment on Liability for Generic Products Manufactured by Others
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- May 12, 2014
The U.S. District Court for the District of Minnesota granted summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation (“Novartis”) on all “generics liability” claims in the pharmaceutical products liability case, Kruszka v. Novartis Pharm.…
Norfolk Southern Gets Summary Judgment Win on Contractual Claims Against Excess Insurer
- Case
- Insurance Coverage
- March 6, 2014
Norfolk Southern Railway obtained complete victory on its contractual claims against Westchester Fire Insurance Company (“Westchester”) in a coverage dispute in the U.S. District Court for the Southern District of West Virginia. Chief Judge Joseph R.…
Ninth Circuit Affirms Summary Judgment for Novartis
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- February 20, 2014
The Ninth Circuit affirmed the District Court’s award of summary judgment in favor of Novartis Pharmaceuticals Corporation (“Novartis”) in the pharmaceutical products liability case, Luttrell v. Novartis Pharm. Corp., No. 12-35893, 555 F. App’x 710 (9th…
Significant Victory for Porter Hayden in Asbestos Coverage Dispute over Exhaustion of Insurers’ Excess Policies
- Case
- Insurance Coverage
- January 2, 2014
Porter Hayden prevailed on a significant coverage dispute when the U.S. District Court for the District of Maryland confirmed that Maryland’s “horizontal exhaustion” rule requires only exhaustion of the primary policies in a particular year on…
Novartis Wins Again
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- September 6, 2013
Three weeks before a scheduled trial, the U.S. District Court for the Eastern District of Tennessee granted summary judgment for Novartis Pharmaceuticals in Payne v. Novartis Pharm. Corp., No. 1:12-CV-77 (E.D. Tenn. Sept. 6, 2013). Senior…
Arizona Federal Court Determines Novartis Warnings Adequate and Grants Summary Judgment
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- July 2, 2013
The U.S. District Court for the District of Arizona granted Novartis Pharmaceuticals Corporation’s (“NPC”) motion for summary judgment based on adequacy of warnings and lack of proximate (or “warnings”) causation in D’Agnese v. Novartis Pharm. Corp.,952…
Western District of Oklahoma Grants Novartis Summary Judgment in Zometa Case
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 28, 2013
The U.S. District Court for the Western District of Oklahoma granted Novartis Pharmaceuticals Corporation’s motion for summary judgment in Shrum v. Novartis Pharm. Corp., Case No. CIV-12-1057-C (W.D. Okla. June 28, 2013). The plaintiff claimed that…
California Jury Returns Defense Verdict for Novartis
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 26, 2013
After a two-week long trial, a jury in the Eastern District of California returned a verdict in favor of Novartis Pharmaceuticals Corporation in Hill v. Novartis Pharm. Corp., No. 1:06-cv-00939-JSR-SAB (E.D. Cal. June 26, 2013). Judge…
Louisiana Federal Court Grants Summary Judgment to Novartis After Excluding Plaintiff’s Expert Witnesses
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- June 14, 2013
The U.S. District Court for the Western District of Louisiana granted Novartis Pharmaceuticals Corporation’s Daubert motion and so excluded plaintiff’s causation expert witnesses and then granted summary judgment in favor of Novartis in Perkins v. Novartis…